XML 33 R20.htm IDEA: XBRL DOCUMENT
v3.26.1

Stock Options and Restricted Stock Units | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Stock Options and Restricted Stock Units | Note 9: Stock Options and Restricted Stock Units On June 7, 2023, the shareholders of the Company approved the 2023 Equity Incentive Plan (the “2023 Plan”). Under the terms of the 2023 Plan, the Company is authorized to issue incentive awards for common stock up to 300,000 shares to employees and other personnel. The awards may be in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units and performance awards. The 2023 Plan is effective through April 1, 2033. As of December 31, 2025, there are 318,166 shares which remain to be granted under the 2023 Plan, including 131,826 shares assumed under the Company’s previous 2014 Equity Incentive Plan, as amended. The following is a summary of stock options issued during the year ended December 31, 2025 and 2024:
Schedule of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Options Outstanding |  |  | Range of Exercise Price |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |
Balance on December 31, 2023 |  |  | 106,750 |  |  | $ | 6.80 – 27.71 |  |  | $ | 22.32 |  |  | $ | 176,360 |
Options granted |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Options exercised |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Options forfeited/cancelled |  |  | (47,000 | ) |  |  | 9.26 – 26.00 |  |  |  | 21.97 |  |  |  | – |
Balance on December 31, 2024 |  |  | 59,750 |  |  |  | 6.80 – 27.71 |  |  |  | 22.60 |  |  |  | 10,700 |
Options granted |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Options exercised |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Options forfeited/cancelled |  |  | (9,750 | ) |  |  | 10.75 – 27.71 |  |  |  | 20.51 |  |  |  | – |
Balance on December 31, 2025 |  |  | 50,000 |  |  | $ | 6.80 – 27.71 |  |  | $ | 23.01 |  |  | $ | 11,800 |
The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e. the aggregate difference between the closing price of the Company’s common stock on December 31, 2025 and 2024 of $9.30 and $8.94, respectively, and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2025 and 2024. As of December 31, 2025, there was $105,000 of unrecognized compensation cost related to stock options, which will be recognized through 2027. The following is a summary of unvested stock options during the year ended December 31, 2025 and 2024:
Schedule of unvested stock options |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Options Outstanding |  |  | Weighted Average Exercise Price |  |  | Weighted Average Grant Date Fair Value |
Balance on December 31, 2023 |  |  | 65,250 |  |  |  | 26.78 |  |  |  | 13.12 |
Options granted |  |  | – |  |  |  | – |  |  |  | – |
Options vested |  |  | (27,750 | ) |  |  | 27.05 |  |  |  | 13.18 |
Options forfeited/cancelled |  |  | (15,000 | ) |  |  | 26.00 |  |  |  | 11.87 |
Balance on December 31, 2024 |  |  | 22,500 |  |  |  | 26.98 |  |  |  | 13.89 |
Options granted |  |  | – |  |  |  | – |  |  |  | – |
Options vested |  |  | (7,500 | ) |  |  | 26.98 |  |  |  | 13.89 |
Options forfeited/cancelled |  |  | – |  |  |  | – |  |  |  | – |
Balance on December 31, 2025 |  |  | 15,000 |  |  |  | 26.98 |  |  |  | 13.89 |
The following table summarizes information about stock options outstanding and exercisable on December 31, 2025:
Schedule of stock options outstanding and exercisable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Options Outstanding |  |  | Options Exercisable |
Exercise Price Range |  | Number |  |  | Weighted Average Remaining Contractual Life (in Years) |  |  | Weighted Average Exercise Price |  |  | Number |
$0.01 - 8.00 |  |  | 5,000 |  |  |  | 0.89 |  |  |  | 6.80 |  |  |  | 5,000 |
$8.01 - 11.00 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
$11.01 - 16.00 |  |  | 7,500 |  |  |  | 3.16 |  |  |  | 13.21 |  |  |  | 7,500 |
$16.01 - 27.00 |  |  | 30,000 |  |  |  | 7.01 |  |  |  | 26.98 |  |  |  | 15,000 |
$27.01 – 27.71 |  |  | 7,500 |  |  |  | 6.05 |  |  |  | 27.71 |  |  |  | 7,500 |
Total |  |  | 50,000 |  |  |  | 5.68 |  |  |  | 23.01 |  |  |  | 35,000 |
Of the 50,000 stock options outstanding, 20,926 are non-qualified stock options. All options have been registered with the SEC. The following is a summary of restricted stock units issued during the years ended December 31, 2025 and 2024:
Schedule of restricted stock units |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of RSUs Outstanding |  |  | Weighted Average Grant Date Fair Value |  |  | Aggregate Intrinsic Value |
Balance on December 31, 2023 |  |  | 94,832 |  |  | $ | 25.90 |  |  | $ | 2,456,149 |
Units granted |  |  | 43,666 |  |  |  | 12.41 |  |  |  | 541,932 |
Units vested/issued |  |  | (18,999 | ) |  |  | 20.26 |  |  |  | (384,830 | )
Units forfeited |  |  | (24,333 | ) |  |  | 25.85 |  |  |  | (628,984 | )
Balance on December 31, 2024 |  |  | 95,166 |  |  |  | 20.85 |  |  |  | 1,984,267 |
Units granted |  |  | 56,662 |  |  |  | 10.93 |  |  |  | 619,316 |
Units vested/issued |  |  | (30,083 | ) |  |  | 15.62 |  |  |  | (469,896 | )
Units forfeited |  |  | – |  |  |  | – |  |  |  | – |
Balance on December 31, 2025 |  |  | 121,745 |  |  |  | 17.53 |  |  |  | 2,134,190 |
During the year ended December 31, 2025, the Company granted 56,662 shares of restricted stock units to employees, contractors and the Board of Directors, which vest at various intervals over the next 3 years. The average grant date fair value of these grants was $10.93 per share during the year ended December 31, 2025. During the year ended December 31, 2025, 30,083 restricted stock units with a grant date average intrinsic value of $15.62 per share, vested and exercised. As of December 31, 2025, there was $669,000 of unrecognized compensation cost related to our unvested restricted stock units, which will be recognized through 2028. During the years ended December 31, 2025 and 2024, the Company recorded compensation expense of $884,000 and $684,000, respectively, related to stock options and restricted stock units.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration